HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 337-348 of 4,505
Behavioral study icon
Not Yet RecruitingACTRN12624000357550

Hybrid: Integrating Virtual Reality, Neurofeedback and Cognitive Behaviour Therapy for Treatment of Hearing Voices in Young People

Official study title

Hybrid: Integrating Virtual Reality, Neurofeedback and Cognitive Behaviour Therapy for Treatment of Hearing Voices in Young People Experiencing Psychosis

This study isn't recruiting yet.

Multiple locations, including Parkville
SchizophreniaInterventional studyAges 15–25
Countries
Australia
Sponsor
Barnaby Nelson
Drug study icon
RecruitingEUCTR 2017-001170-42

An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In...

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Gdańsk
SchizophreniaHistorical research record
Countries
Poland
Sponsor
SyneuRx International (Taiwan) Corp
Drug study icon
RecruitingEUCTR 2022-001582-12

Open, multicenter, randomized clinical trial to evaluate the efficacy and safety of aripiprazole vs paliperidone / risperidone using multi-omics data in patients with a first psychotic episode.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Barcelona
SchizophreniaHistorical research record
Countries
Spain
Sponsor
Consorcio Centro de Investigacion Biomedica en Red (CIBER)
Drug study icon
RecruitingNCT04478838

"Extended" (Alternate Day) Antipsychotic Dosing

Official study title

"Re-examining Maintenance Antipsychotic Treatment in Schizophrenia: "Extended" Antipsychotic Dosing"

In Toronto
SchizophreniaMedication studyAges 18+
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Drug study icon
RecruitingNCT07369154

52-week Open Label Safety-Tolerability Study

What is this study about?

This study evaluates the safety of LB-102 for people with schizophrenia.

Multiple locations, including Chandler
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
LB Pharmaceuticals Inc.
Drug study icon
RecruitingNCT07615426

Aticaprant for schizophrenia

What is this study about?

This study evaluates the safety of Aticaprant for people with schizophrenia.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
Janssen Research & Development, LLC
Drug study icon
RecruitingNCT07221877

Effect of KarXT on Urological Safety

Official study title

A 12-month Open-label, Phase 4 Multicenter Safety Study to Evaluate the Effect of KarXT on Voiding Dynamics and Urological Safety

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Bristol-Myers Squibb (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.